Acorda Therapeutics Inc.

NASDAQ: ACOR · Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM

Acorda Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.01 -0.04 -0.04
PEG Ratio
-0.00 0.00 0.00
PS Ratio
0.03 0.02 0.03
PB Ratio
-0.02 0.03 0.03
P/FCF Ratio
-0.22 -0.12 -0.1
P/OCF Ratio
-0.22 -0.12 -0.1
OCF/S Ratio
-0.12 -0.18 -0.32
Debt / Equity Ratio
-1.21 1.85 1.26
Quick Ratio
0.26 1.83 1.55
Current Ratio
0.33 2.16 1.89
Asset Turnover
1.00 0.30 0.28
Interest Coverage
-0.74 -1.49 -2.57
Return on Equity
1.60 -0.7 -0.69
Return on Assets
-2.15 -0.17 -0.23
Return on Invested Capital
-0.26 -0.22 -0.18
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.61 0.74 0.68
Net Profit Margin
-2.15 -0.56 -0.81
Pretax Profit Margin
-2.52 -0.3 -0.85
Operating Profit Margin
-0.2 -0.35 -0.6
FCF Margin
n/a n/a n/a
EBITDA Margin
0.07 -0.08 -0.35